We're #hiring a new Corporate Recruiter in Columbia, South Carolina. Apply today or share this post with your network.
The Ritedose Corporation
制药业
Columbia,SC 5,843 位关注者
Manufacturing | Inhalation | Oral Solutions | 503B Outsourcing
关于我们
The Ritedose Corporation is a leader in blow-fill-seal(BFS) manufacturing of small fill volume pharmaceutical unit dose sterile and non-sterile liquids. We specialize in manufacturing inhalation products, eye drops, eardrops and unit dose oral liquids.
- 网站
-
https://www.ritedose.com
The Ritedose Corporation的外部链接
- 所属行业
- 制药业
- 规模
- 501-1,000 人
- 总部
- Columbia,SC
- 类型
- 私人持股
- 创立
- 1995
- 领域
- Contract Pharmaceutical Blow-Fill-Seal Manufacturer
地点
-
主要
1 Technology Circle
US,SC,Columbia,29203
The Ritedose Corporation员工
-
Joseph Boorady
Board Director l Global Executive l Investor l Advisor l M&A l Medical Devices l Biotech l Private Equity
-
Maris Lazdins
Regulatory Affairs Operations Specialist III at The Ritedose Corporation, (TRC)
-
Scot Thoroughman
Pharmaceutical Professional
-
Angie Koen
VP Technical Services, The Ritedose Corporation
动态
-
We're #hiring a new Talent Acquisition Manager in Columbia, South Carolina. Apply today or share this post with your network.
-
In pharmaceutical manufacturing, putting people first means prioritizing patient care, employee well-being, and ethical practices. At Ritedose, we’re committed to this principle every day, ensuring our innovations and work environment reflect our core values.?? ? Contact us at Ritedose.com to learn more.? ? #PeopleFirst #PharmaCare #PatientFocused?
-
Did you see the news? Verona Pharma has partnered with?Ritedose as the development and manufacturing partner of Ohtuvayre, a new novel product for Chronic Obstructive Pulmonary Disease (COPD).? ? Thank you Contract Pharma for this great coverage of last week’s announcement.? ? Read it here: ? https://lnkd.in/eDEUPYEk? ? Learn more at Ritedose.com?
-
This Thursday and Friday, Ritedose will exhibit at the 23rd Annual Contract Pharma Contracting and Outsourcing Conference. Visit Carol Morgan and Robert Sikora at table #2 to learn more about our industry-leading Blow-Fill-Seal (BFS) technology, pharmaceutical medication manufacturing capabilities, and our record of delivering billions of top-quality doses with no patient interruptions. See you there!? ? Visit?https://lnkd.in/exed__nv??to learn more.
-
Enjoy some great photos from our team-wide Ritedose Employee Appreciation Day. This event celebrated both the hard work of Ritedose employees and recognized the official launch of our partnership with Verona Pharma as the developing and manufacturing partner of Ohtuvayre (ensifentrine), a new novel COPD drug.? ? Thank you to our team for their dedication and commitment each and every day!? ? #EmployeeAppreciation #ThankYouTeam?
-
+4
-
At Ritedose, we know the heart of who we are is our incredible team!?? ? Their dedication, passion, and expertise drive us in everything we do. Every minute of time and care invested in producing life-saving medicines makes a difference in the lives of people across the country.? ? Today is the kickoff to Ritedose’s Employee Appreciation Day – not only is this event?our way of honoring and recognizing the hard work and commitment across our team, but it’s also a way to celebrate our partnership with Verona Pharma as the developing and manufacturing partner in the launch of Ohtuvayre (ensifentrine), a new novel COPD drug.? ? Verona shares our values to Uphold Each Other, and this event is no exception. We’ve worked hard together these last months, and we are excited to thank the team this week.? ? #EmployeeAppreciation #ThankYouTeam?
-
Ritedose, the largest CDMO in the United States specializing in sterile Blow Fill Seal (BFS) production of unit dose solutions for the respiratory market, is proud to partner with?Verona Pharma?(Nasdaq: VRNA) as the development and manufacturing partner of Ohtuvayre, a new novel product for Chronic Obstructive Pulmonary Disease (COPD). ? Our entire dedicated team at Ritedose is proudly rolling out national launch quantities of Ohtuvayre now, so this novel product can be available to all the COPD patients who need it. For more information on how Ritedose can partner with you, visit?www.ritedose.com.
We’re excited to announce that on September 17th, Verona Pharma will ring the Nasdaq #closingbell, to celebrate the recent launch of #Ohtuvayre (ensifentrine). We’re excited to share this moment with our team, partners, and the broader healthcare community.
-
We’re excited for the opportunity to be the development and manufacturing partner for Verona Pharma in the launch of Ohtuvayre (ensifentrine), a new novel COPD drug with a unique mechanism of action.?? ? Clinical data from the Phase III ENHANCE trials demonstrated statistically significant improvements in lung function, symptoms, and quality of life for patients. Data showed a 36% reduction in rate of exacerbations over 24 weeks. Ohtuvayre demonstrated clinical benefits both alone and when used with other maintenance therapies.? ? Find out more about our partnership with Verona: https://lnkd.in/e37SNYMM?
-
Will you be attending the 23rd Annual Contract Pharma Contracting and Outsourcing Conference? ? ? This conference offers a lineup of speakers and insight into key industry topics, and Ritedose will be exhibiting! We’re?honored to attend as an industry-leading CDMO known for delivering billions of top-quality doses with no patient interruptions.? ? Stop by Table?#2 to visit with our team members, Carol Morgan and Robert Sikora, and learn how we can provide uninterrupted patient access to quality medications for your organization.?? ? See you at the Hyatt Regency in New Brunswick, NJ. on September 26-27th. Visit?https://lnkd.in/dGRnVmn?to learn more about the event.?